- Home
- GHRS vs AOD Comparison
GHRS vs AOD Comparison
Compare GHRS & AOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GHRS | AOD |
|---|---|---|
| Founded | 2018 | 2006 |
| Country | Ireland | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 892.0M | 970.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | GHRS | AOD |
|---|---|---|
| Price | $13.05 | $9.68 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $30.11 | N/A |
| AVG Volume (30 Days) | 247.9K | ★ 423.5K |
| Earning Date | 11-06-2025 | 01-01-0001 |
| Dividend Yield | N/A | ★ 12.95% |
| EPS Growth | N/A | ★ 213.63 |
| EPS | N/A | ★ 1.93 |
| Revenue | N/A | ★ $72,962,082.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $4.44 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.72 | $6.99 |
| 52 Week High | $20.50 | $9.14 |
Technical Indicators
Market Signals| Indicator | GHRS | AOD |
|---|---|---|
| Relative Strength Index (RSI) | 41.50 | 57.76 |
| Support Level | $13.94 | $9.63 |
| Resistance Level | $15.00 | $9.74 |
| Average True Range (ATR) | 0.84 | 0.08 |
| MACD | -0.15 | 0.02 |
| Stochastic Oscillator | 3.99 | 80.69 |
Price Performance
Historical ComparisonAbout GHRS GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
About AOD abrdn Total Dynamic Dividend Fund of Beneficial Interest
Aberdeen Total Dynamic Dividend Fund is a diversified, closed-end management investment company. Its investment objective is to seek high current dividend income. The company also focuses on the long-term growth of capital as a secondary investment objective. The fund invests in foreign securities, including direct investments in securities of foreign issuers and investments in depositary receipts that represent indirect interests in securities of foreign issuers. Its portfolio consists of securities from Information Technology, Financial, Healthcare, and Industrials among other sectors.